Non-Covalent BTK Inhibitor Yields High Response Rate in Pretreated CLL

[MEDPAGE TODAY]( Daily Headlines Wednesday, July 05, 2023 Today's Top Stories for {NAME} [ONCOLOGY/HEMATOLOGY]( [Non-Covalent BTK Inhibitor Yields High Response Rate in Pretreated CLL]( [NEUROLOGY]( [Dementia Tied to Fluctuations in Blood Lipids Over Time]( [CARDIOLOGY]( [First Dual-Chamber Leadless Pacemaker Approved by FDA]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Transforming Treatment and Management Strategies for Patients With AML]( [OPINION]( [Health Emergencies Don't Discriminate by Political Party]( [CASE STUDIES]( [Breast Cancer Patient Develops Heart Palpitations and Dyspnea]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [OB/GYN]( [Maternal Mortality Remains 'Unacceptably High' in the U.S., Study Shows]( CME SPOTLIGHT [Transforming HR+/HER2- Breast Cancer Care: Real-world Patient and Provider Perspectives]( [OPINION]( [Making Care Primary Again?]( [MEETING COVERAGE]( [EphrinB2 Expression in Urothelial Cancer Tied to Checkpoint Inhibitor Activity]( [PSYCHIATRY]( [Stimulants for ADHD in Childhood Not Linked to Substance Use Later On]( CME SPOTLIGHT [COVID-19 Prevention for Immunocompromised Individuals]( [NEUROLOGY]( [Confirmed: Spinal Cord Injury Can Suppress Immune Function]( [OPINION]( [I Can't Guarantee Your Next Round of Chemo]( [AAD READING ROOM]( [Atopic Eczema, Psoriasis -- and Their Long-Term Impact on Mental Health]( CME SPOTLIGHT [Navigating the Latest Evidence on Multi-Cancer Early Detection Technologies]( [PODCASTS]( [Addressing Healthcare Inequities Through Patient Relationships]( [THE BREAK ROOM]( [Spell Check-Up: Prove Your Spelling Proficiency]( [ASCO READING ROOM]( [Presurgical Testing Guidelines Lower Costs in Endometrial Cancer]( CME SPOTLIGHT [Evidence-Based Management of Adverse Effects of Immunotherapy in Relapsed/Refractory Multiple Myeloma]( [MEETING COVERAGE]( [A Changing Landscape in First-Line Endometrial Cancer]( [ASCO READING ROOM]( [Sherene Loi, MD, PhD, on Biomarkers and Immunotherapy Outcomes in TNBC]( CME SPOTLIGHT [Clinical Evidence for Current and Emerging Therapies in Relapsed/Refractory Multiple Myeloma]( # Weekly Survey [What Grade Does Walensky Get?]( President Biden commended [outgoing]( CDC Director Rochelle Walensky, MD, MPH, for her 'unwavering focus on the health of every American,' but she has faced a fair amount of criticism for the agency's handling of the pandemic.[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-07-05&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011